The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Aclaris Therapeutics Inc (ACRS) COM 00461U105   825,465 434,455 SH   SOLE   434,455 0 0
Bicara Therapeutics Inc. (BCAX) COM 055477103   8,983,231 568,919 SH   SOLE   568,919 0 0
Biomea Fusion Inc (BMEA) COM 09077A106   4,138,489 2,048,757 SH   SOLE   2,048,757 0 0
BridgeBio Pharma Inc. (BBIO) COM 10806X102   316,294,395 6,089,611 SH   SOLE   6,089,611 0 0
CalciMedica, Inc. (CALC) COM NEW 38942Q202   1,602,842 521,114 SH   SOLE   521,114 0 0
Compass Pathways Plc (CMPS) SPONSORED ADS 20451W101   6,866,935 1,198,418 SH   SOLE   1,198,418 0 0
Marker Therapeutics, Inc. (MRKR) COM NEW 57055L206   290,425 325,370 SH   SOLE   325,370 0 0
Monte Rosa Therapeutics Inc (GLUE) COM 61225M102   10,909,973 1,472,331 SH   SOLE   1,472,331 0 0
Nuvation Bio Inc. (NUVB) COM CL A 67080N101   10,954,438 2,960,659 SH   SOLE   2,960,659 0 0
OnKure Therapeutics, Inc. (OKUR) COM CL A 68277Q105   243,669 88,607 SH   SOLE   88,607 0 0
Syndax Pharmaceuticals, Inc. (SNDX) COM 87164F105   20,265,644 1,316,806 SH   SOLE   1,316,806 0 0
Verona Pharma plc (VRNA) SPONSORED ADS 925050106   65,664,212 615,352 SH   SOLE   615,352 0 0
Scholar Rock Holding Corporation (SRRK) COM 80706P103   2,868,634 77,031 SH   SOLE   77,031 0 0
BridgeBio Oncology Therapeutics (BBOT) COM NEW 107924102   6,538,358 564,625 SH   SOLE   564,625 0 0